DEARGEN advances the treatment of rare and intractable diseases through the integration of AI and collective intelligence.
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology.
It specializes in genome data analysis, biomarker prediction, molecule selection and optimization.
DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new drugs.